FT : DMGT to return £900m to shareholders from Euromoney stake

DMGT to return £900m to shareholders from Euromoney stake
Investors to be offered shares in financial publisher at a discount

The parent company behind the Daily Mail newspaper has announced plans to return almost £900m to shareholders by offloading shares in financial publisher Euromoney, in a move that will boost ownership over the company by chairman Lord Rothermere.

Under the plan revealed on Sunday, Daily Mail and General Trust will hand over its entire holding in Euromoney to some shareholders at a discount, in addition to returning £200m of cash as part of a plan to simplify its business.

Chairman Lord Rothermere, who owns shares in Euromoney through two investment vehicles, will not participate in the scheme. Because some shareholders will exchange their DMGT shares for Euromoney shares, the transaction means his family’s stake in DMGT will increase from 24 per cent to 36 per cent.

Paul Zwillenberg, chief executive of DMGT, said: “The proposed distributions that we have announced today are fully aligned with our strategic priorities of increasing the focus of our portfolio and maintaining financial flexibility, whilst at the same time improving the efficiency of our balance sheet.

“In total, the distributions will result in almost £900m of assets being returned to shareholders, who will benefit from direct ownership of Euromoney while retaining exposure to a simplified DMGT group.”

The deal is the latest step by DMGT to simplify its business after selling EDR, a commercial real estate service, and its stake in ZPG, the company behind property website Zoopla. It comes as media companies grapple with falling advertising revenues as tech companies hoover up advertising dollars and Brexit hits companies’ budgets.

The parent company behind the Daily Mail newspaper has announced plans to return almost £900m to shareholders by offloading shares in financial publisher Euromoney, in a move that will boost ownership over the company by chairman Lord Rothermere.

Under the plan revealed on Sunday, Daily Mail and General Trust will hand over its entire holding in Euromoney to some shareholders at a discount, in addition to returning £200m of cash as part of a plan to simplify its business.

Chairman Lord Rothermere, who owns shares in Euromoney through two investment vehicles, will not participate in the scheme. Because some shareholders will exchange their DMGT shares for Euromoney shares, the transaction means his family’s stake in DMGT will increase from 24 per cent to 36 per cent.

Paul Zwillenberg, chief executive of DMGT, said: “The proposed distributions that we have announced today are fully aligned with our strategic priorities of increasing the focus of our portfolio and maintaining financial flexibility, whilst at the same time improving the efficiency of our balance sheet.

“In total, the distributions will result in almost £900m of assets being returned to shareholders, who will benefit from direct ownership of Euromoney while retaining exposure to a simplified DMGT group.”

The deal is the latest step by DMGT to simplify its business after selling EDR, a commercial real estate service, and its stake in ZPG, the company behind property website Zoopla. It comes as media companies grapple with falling advertising revenues as tech companies hoover up advertising dollars and Brexit hits companies’ budgets.

WSJ : Investors Scale Back Inflation Bets, Signaling Doubts About Growth

Investors Scale Back Inflation Bets, Signaling Doubts About Growth
A widely tracked measure of inflation expectations is mired below 2% even in a tight U.S. job market

Bets on a pickup in inflation are falling out of favor, underscoring investors’ skepticism that the U.S. economy will be able to turn stronger after a soft start to the year.

The growth outlook has dimmed over the past year as measures of manufacturing activity, consumer spending and business confidence have waned. The cool-down in the economy helped keep inflation from running past the Federal Reserve’s 2% target for a seventh straight year in 2018.

The fact that inflation has continued to undershoot targets has allowed the Fed to suggest it will pause its rate-increase campaign, helping the S&P 500 rise 12% in 2019 and notch its best two-month start to the year in decades. But many bond investors have taken a more pessimistic view, questioning whether muted price increases are another sign that prospects for the economy and earnings are dimming.

Investors will get another look at where inflation is headed on Friday, when the Labor Department publishes its monthly jobs report.

“I’m in the camp of those who are doubtful,” said Zhiwei Ren, managing director and portfolio manager at Penn Mutual Asset Management.

Mr. Ren said he bought Treasury inflation-protected securities in 2017 but wound down purchases last year and believes he won’t buy much, if any, this year. TIPS offer yields—albeit relatively small ones—that rise together with inflation, making them most desirable to investors when they believe prices across the economy are heading higher.

“I thought 2017 would be a good year because that’s the year we all talked about synchronized global growth,” Mr. Ren said. “But we didn’t see [inflation], and now, all the data shows a slowdown.”

A widely tracked measure of investors’ expectations for average annual inflation over the next decade, known as the 10-year break-even rate, has remained below the Fed’s 2% target in 2019. Measured by the gap between yields on the 10-year Treasury note and 10-year TIPS, the break-even rate was at 1.95% on Thursday. That is up from recent lows in December but still below the four-year high of 2.18% hit in May, according to FactSet.

Demand for other products that hedge portfolios against inflation has also waned in recent months. The Schwab U.S. TIPS exchange-traded fund is on track to post a quarterly outflow for the first time since 2013, according to Lipper.

And surveys show investors are growing increasingly doubtful that the economy will heat up. Among global fund managers surveyed by Bank of America in February, 55% expected below-trend growth and inflation over the next year, the highest share since December 2016.

Few—including Mr. Ren—believe that the U.S. is on the brink of recession. The unemployment rate remains near multidecade lows. For 100 consecutive months, the labor market has added more jobs than it has lost. Wages have risen at least 3% on a year-over-year basis for six straight months, and data Thursday showed gross domestic product rose more than expected in the final quarter of 2018. In the past, these factors—especially low unemployment—would have prompted investors to fret about inflation.

Yet a tight labor market hasn’t been enough to keep inflation running consistently at the Fed’s 2% target. That has stirred debate among economists about whether factors like the diminishing power of unions and globalization have created an environment in which inflation is likely to stay muted.

One factor that could change the picture: the Fed.

In recent months, Fed officials have begun publicly discussing potential changes to how they define their inflation target. One approach would have the Fed aim for an average of 2% inflation over several years, meaning it would deliberately seek modest overshoots of the 2% target during good times to make up for falling below target during recessions. The Fed would want slightly higher inflation to reduce the risk of deflation in a slowdown and to give investors and consumers confidence that growth would continue. Officials have said they won’t make any changes before early next year.

“These are incredibly dovish concepts, a complete change in the response function of the Fed,” said Matt Toms, chief investment officer of fixed income at Voya Investment Management. “It’s suggesting the Fed won’t immediately respond to kill inflation.”

Traders have begun pricing in a small chance of the Fed lowering short-term interest rates this year, a move that could help nudge inflation higher by lowering the cost for businesses and households to borrow and invest. Federal-funds futures, which track market-based expectations for monetary policy, showed Wednesday a 20% chance of the Fed lowering rates by year-end, according to CME Group. That compares with around 4.1% at the start of the year.

So far, though, there are few signs of investors positioning for an uptick in growth and a corresponding boost to inflation.

The 10-year Treasury yield, used as a reference rate for everything from mortgages to auto loans, has drifted along in a relatively narrow range this year after reaching multiyear highs above 3% in 2018. The 10-year yield tends to rise when investors are confident about growth and retreat when they are less sure about the economic outlook. Yields rise as bond prices fall.

Mutual funds and exchange-traded funds tracking equities have also logged steep outflows, while those offering investors exposure to bonds are posting net inflows so far in 2019, according to a Bank of America analysis of EPFR Global data.

That pattern suggests that investors aren’t convinced that the economy is about to heat up. Inflation tends to make Treasurys less attractive to investors, since it chips away at the purchasing power of their fixed payouts.

“The Fed can do everything they try to do to increase inflation expectations, but the market is doubtful they can achieve that,” Mr. Ren said.

WSJ : U.S., China Close In on Trade Deal

U.S., China Close In on Trade Deal
Both countries could lift some tariffs imposed last year, and Beijing would agree to ease restrictions on American products

China and the U.S. are in the final stage of completing a trade deal, with Beijing offering to lower tariffs and other restrictions on American farm, chemical, auto and other products and Washington considering removing most, if not all, sanctions levied against Chinese products since last year.

The agreement is taking shape following February’s talks in Washington, people briefed on the matter on both sides said. They cautioned that hurdles remain, and each side faces possible resistance at home that the terms are too favorable to the other side.

Despite the remaining hurdles, the talks have progressed to the extent that a formal agreement could be reached at a summit between President Trump and Chinese President Xi Jinping, probably around March 27, after Mr. Xi finishes a trip to Italy and France, individuals with knowledge of the plans said.

As part of a deal, China is pledging to help level the playing field, including speeding up the timetable for removing foreign-ownership limitations on car ventures and reducing tariffs on imported vehicles to below the current auto tariff of 15%.

Beijing would also step up purchases of U.S. goods—a tactic designed to appeal to President Trump, who campaigned on closing the bilateral trade deficit with China. One of the sweeteners would be an $18 billion natural-gas purchase from Cheniere Energy Inc., people familiar with the transaction said.

The two sides continue to negotiate over issues involving Chinese industrial policy the U.S. argues gives Chinese domestic firms an advantage, especially state-owned enterprises. Last week, U.S. Trade Representative Robert Lighthizer said the provisions involving protecting intellectual property total nearly 30 pages out of a working document of more than 100 pages.

U.S. and Chinese negotiators are also working on setting up a mechanism through which complaints by U.S. companies could be addressed. The plan under discussion calls for bilateral meetings of officials from both countries to adjudicate disputes. If those talks don’t produce agreement, Mr. Lighthizer has said, the U.S. could impose tariffs.

Others involved in the talks said the U.S. is pressing Beijing to agree not to retaliate—at least in some cases—if the U.S. levies sanctions. That would be a big concession for Beijing negotiators, who say they want to make sure the deal doesn’t turn out to be an unequal treaty for China of the sort imposed by Western powers in the 19th century.

Even so, China hawks in the U.S. are concerned that enforcement measures may not be strong enough and will tie down the U.S. in endless talks.

“The whole process is a fraud,” said Derek Scissors, a China expert at the American Enterprise Institute, who argues the U.S. could better enforce its will by taking unilateral actions rather than getting hooked into consultations. Former White House strategist Steve Bannon urged the administration to increase tariffs to pressure China to agree to tougher terms even if that meant lengthier negotiations and market uncertainty.

“For Trump to get the structural reforms he wants and the country needs could take the rest of 2019 to negotiate,” Mr. Bannon said.

It isn’t yet clear whether conservative U.S. media, which has Mr. Trump’s ear, will pick up the criticism.

For the Chinese, linking the Florida visit to Mr. Xi’s European trip is a way to blunt the impression that he is traveling directly to Mr. Trump’s estate to make concessions.

In recent weeks, Mr. Xi has summoned senior officials from across China to warn them about “major risks” to the world’s No. 2 economy, and his administration issued new party directives demanding “unity and concerted action.”

A test of Mr. Xi’s authority will unfold over the next two weeks, when roughly 3,000 lawmakers gather in Beijing to review the government’s economic blueprint for the year.

One wild card in the U.S.-China negotiations is the impact of Mr. Trump’s failed summit in Vietnam with North Korean leader Kim Jong Un. U.S. officials said they hope Mr. Xi learns from that episode that Mr. Trump would reject an offer he considers inadequate. But they fear Beijing might take the opposite lesson: that Mr. Trump is desperate for a win.

“His failure to get a deal in Vietnam increases the pressure on him to get a deal with the Chinese,” said Fred Bergsten, founder of the Institute for International Economics in Washington.

Both sides also recognize the need to win domestic support. Chinese Vice Premier Liu He, the lead negotiator for Mr. Xi, has been holding meetings with various ministries and agencies to build consensus within a bureaucracy that is anything but monolithic.

Mr. Lighthizer, meanwhile, plans to go to Michigan this week to talk to the United Auto Workers. He told Congress last week that he has tried to incorporate specific requests from labor, business, farmers and lawmakers in a deal.

Any deal is likely to be welcome by markets, which have risen on the news that chances of an end to the trade battle were increasing. But given the administration’s heated rhetoric on China—Mr. Lighthizer last week said he considered Beijing an existential challenge to the U.S.—the provisions are already being criticized as inadequate, especially measures to remake Chinese industrial policies.

In a move that would bolster administration’s claims of the benefits of a deal, China’s state-owned China Petroleum & Chemical Corp., known as Sinopec, would agree to buy $18 billion of liquefied natural gas from Cheniere, people familiar with the transaction said.

Cheniere would start delivering LNG to the Chinese counterpart as soon as 2023. Chinese banks could provide financing as part of the deal in the range of $3 billion to build additional facilities to meet the demand. The deal is still under negotiation and isn’t completed.

“That would be a strong signal that there will be other (contracts) to follow,” said Charlie Riedl, executive director of the Center for Liquefied Natural Gas, a trade association.

China has hit U.S. LNG with 15% tariffs, as part of the trade fight, and has been buying the product mainly from Qatar, Australia and Malaysia.

Other purchases include soybeans and other agricultural goods. In recent talks, Beijing has also discussed reducing tariffs and other barriers that have limited the sale of American-made chemicals and agricultural products, such as ethanol, which now face 70% Chinese retaliatory tariffs; an ethanol byproduct, dried distillers grains, which is used to feed cattle; and polysilicon, a raw material in solar panels that was hit with 57% tariffs as part of an earlier trade fight with China.

Mr. Trump on Friday tweeted that he asked Beijing “to immediately remove all Tariffs on our agricultural products (including beef, pork, etc.)” in part, because he last week scrapped plans to raise tariffs on $200 billion of Chinese goods to 25% from 10% on March 2 as scheduled.

There has been less progress on other issues dividing the two nations, especially China’s industrial policies and subsidies. Beijing considers that support crucial to its state-led development plan and maintaining the Communist Party’s rule.

Yang Guangpu, an associate research fellow at the Development Research Center, a think tank under China’s State Council, said Beijing is taking steps to enable state companies to operate more like commercial entities.

“China is carrying out [state-company] reforms in an orderly fashion, and won’t change the pace because of the trade tensions with the U.S.,” Mr. Yang said.

Beijing has pledged to remove “market distorting” subsidies, people tracking the talks said, but some in the administration consider that insufficient because Beijing doesn’t specifically enumerate its subsidies, at the central government and local level, and specify which ones it will eliminate.

FT : Balenciaga’s brilliant ‘street’ wear looked like everything — and nothing —

Balenciaga’s brilliant ‘street’ wear looked like everything — and nothing — you’ve seen before
Balenciaga and Hermès AW19 show reports

The Balenciaga set was a vast black box that stank of asphalt. The collection reeked of street. It was brilliant, bold and contemporary — and there wasn’t a sneaker to be seen.

In a season that has been big on retro references and the allure of the bourgeoisie, Demna Gvasalia’s modern take on Paris style made for a powerful statement. There was lots of sober suiting, casual outerwear and simple evening dresses, but the cuts and the couture sensibility ensured no two looks (and there were more than 100 of them) were quite the same. It was also a meditation on what is relevant in fashion, a world where the water bottle has been elevated to new luxury status, and the synthetic puffa is more valuable — and desirable — than a fur. At Balenciaga, models slung bottle bags around their bodies, and carried bags that could manage a supermarket run. “I like people who like shopping,” deadpanned Gvasalia of his shoppers. “I depend on people shopping for my job.”

Gvasalia’s show dripped with clever details, while offering new takes on the basics and tailoring tricks that made you stop and stare. The shoulder, already the feature of AW19, was pinched, volumised and pinned from behind. My favourite look of the season so far? An otherwise boring sweater with a suspended band that hovered implausibly above the collar. Worn with a pair of charcoal trousers and a red polka dot tote, it hit that G-spot where function meets true fashion and makes four weeks of shows feel more worthwhile.

It was grown-up, it was polished, it was full of couture details. Balenciaga was born a couture house after all and Gvasalia doesn’t shy away from that — he just keeps his cuts for the things that are important — the suiting, the parkas and those endless, epic coats.

On its own the collection was stunning, if fractionally too long and hard to see. It also provoked all sorts of thoughts about “new luxury”, and the new vogue for the bourgeois that has dictated the season’s mood so far. In many ways Balenciaga’s themes echoed the message of the season, where mature, slightly retro clothes have featured everywhere, from Gucci and Burberry, to Celine and Dolce & Gabbana, and designers have seemed less focused on the youth. I’m not sure a single designer this month has mentioned “the millennial” as a muse.

And there’s been less logomania. In recent seasons, luxury houses (and especially Balenciaga) have branded themselves like sportswear giants, such as Adidas or Nike. For AW19 things have been more subtle: there’s been more focus on the clothes making than the brand name, and while there were still lots of logos at Balenciaga, they were slightly less brash and in your face. On the handbags, where a letter B was used as hardware, the branding was often blackened out.

One hopes it reflects a changing market in which consumers are less interested in buying exorbitantly priced T-shirts and more interested in the quality of the clothes. In the era of the “Amazon puffa”, and at a time where consumers are increasingly focused on value, the emphasis on more “luxurious” clothing might read as an act of self-defence. After all, if you want someone to spend £3,000 on a coat, it should at least look, and feel, smart.

It might explain also the rise of that Seventies “bourgeois” mood — where loafers, equestrian details and headscarves have been key. It’s more sophisticated surely, but you have to wonder how the modern woman will feel about this “lady” sensibility. When I asked Derek Blasberg, the head of fashion and beauty partnerships at YouTube, to describe the style of Silicon Valley at the moment, he answered “yoga”. It’s hard to imagine the wellness empresses of California finishing their spin class and putting on a box-pleat skirt.

Neither would I have wanted to be flaunting a Thatcher-era pussy-bow blouse on Avenue Montaigne this weekend, where the gilets jaunes were out in force, as they have now been for months. Stuck on luxury’s most bougie boulevard on Saturday as huge swaths of demonstrators surrounded the car, my instinct was simply to blend in. Fashion has an almost Marie Antoinette-ish capacity for denial and escaping into fantasy when real life gets too strong. Balenciaga was one of the few brands that seemed grounded in reality. Or at least some awareness of the world around it. The coats were couture style but they came in hazard yellow.

Is fashion’s preoccupation with the signifiers of the propertied classes a rallying call for custom, or a last-ditch cry for help? At Hermès, arguably the brand to which the bourgeois woman most aspires, I asked designer Nadège Vanhee-Cybulski. The heritage brand has been quietly furnishing the world’s wealthiest people for decades, and the padded quilted nappa leather puffas, cashmere coats and printed silk day dresses (inspired by a scarf print) she presented for AW19 were no exception.

And yet she argues that the longevity and power of Hermès is found in its being a “democratic brand”. The house of the astronomically expensive Birkin handbag is democratic? Come off it. “For me, Hermès is about craftsmanship, and humanity. I’m never thinking about transmitting a woman’s status in society,” she continued, “but on the men, and women, who are the experts in the house. I’m purely focused on the skills of the atelier. The craftwork, and the detail. It’s democratic, because everyone can see the beauty in the work.”

Carefully modest, craft-focused and cautious with its marketing, it’s ironic that Hermès is one of the most powerful brands. Its annual revenues amount to more than €5bn, but if you want an anecdotal indicator as to just how well it’s doing, have a wander around any Hermès store. Wherever you are in the world, along with Chanel, Gucci and Louis Vuitton, it’s always, always the busiest one.

That said, and as with many of Vanhee-Cybulski’s collections, I could live with a little less of the house’s expertise. Did those lovely scarf-print blouses really need a pleated trim along the placket, or the ruffle running from the shoulder down the sleeve? Is there a massive demand for tailored leather knickerbockers? And does she always have to show such heavy shoes? I quibble. There were many delicious things here. Such as the black leather caban jacket, with overstitching, and a moss green cashmere coat with leather trims. Quietly stylish, epically expensive and essentially bourgeois. Clothes for people who care more about the quality, and have no interest at all in sticking out.

>>> What to look at today - 2nd & 3rd of February 2019

Equity markets took a breather on fairly low volatility despite another heavy week of corporate earnings to be digested. Potential progress on some global issues hit snags as President Trump cut short his Hanoi summit without reaching any new agreement with North Korea, and as PM May reportedly conceded that the Brexit will have to be delayed from March 29 even if the Parliament supports her plan later this month. Washington was gripped by Congressional testimony from former Trump fixer Michael Cohen, as well as hearings with Fed Chair Powell and US Trade Rep Lighthizer who agreed that the economy looks healthy and would be helped by a resolution to trade tensions.
In corporate news this week, some key earnings emerged from the retail space. JCPenney shares lifted after posting stronger than anticipated earnings and laying out a plan to shutter some stores. L Brands tumbled after missing on earnings and guiding a disappointing FY19 EPS number. Macy’s Q4 beat on the top and bottom line and the company announced it would trim 100 management positions and cut $100M in annual costs. Gap Inc. notched a profit beat and announced plans to spin off its Old Navy division to separate into two independent publicly traded companies. A spate of M&A deals hit the corporate news space this week. Roche boosted its gene therapy portfolio with its acquisition of Spark Therapeutics for $4.3B. GE sold off its life sciences business to Danaher for $21.4B. eBay initiated a strategic review of its asset portfolio amid pressure from investors. The grocery store sector slumped on Friday after a report that Amazon is reportedly launching a new line of grocery stores with a lower price point than its Whole Foods division. Shares of Tesla sold off sharply after the car company made good on its long-promised $35K price point for a pared down version of the Model 3 sedan.

Macro :
- Italy’s League Gains Ground in Ipsos Poll as Five Star Slips
- Goldman, JPMorgan Still See Upside in China Assets After Rally
- May Gets Boost as She Seeks Approval for EU Deal: Brexit Update
- Mueller’s Final Report Will Ignite an Epic War Over Disclosure
- France Plans 5% Digital Tax as Governments Chase Internet Giants

Keep an eye on :
- BMW GY : BMW Group U.S. February Sales Climb 0.2% to 23,558 Vehicles
- BP/ LN : Bidders Said to Emerge In BP’s $7 Billion U.S. Shale Asset Sale
- DAI GY : Mercedes-Benz U.S. Luxury Auto Sales Down 12.5% in February
- DIA SM : DIA Board: LetterOne Capital Increase Doesn’t Solve Co’s Needs
- FB US : Facebook Sues China-Based Companies for Selling Fake Accounts
- FRE GY : Akorn Says to Still Defend Against Fresenius’s Remaining Claim
- III LN : 3i, Greene King, Takeaway.com to Be Added to Stoxx Europe 600
- ISAT LN :
- LIN GY : Linde Delays 10-K Filing; Required Added Time Due to Merger
- LOK LN : Lok’nstore Chairman Sells Shares, Cites Investor Buying Interest
- RR/ LN : Rolls-Royce Seeks Buyer for Nuclear-Equipment Unit: Sunday Times
- RYA ID : Ryanair in Pact With German Pilot Union on Pay, Allowances
- TIT IM : Telecom Italia Sparkle Names Mario Di Mauro New CEO
- UCB BB : Presented positive data from the Phase 2b BE ABLE extension study of bimekizumab in patients with moderate-to-severe chronic plaque psoriasis
- VAO GY : Vapiano to Slow Pace of Restaurant Openings: CEO to Focus
- VOw3 GY : Volkswagen of America Reports Feb. 2019 Sales Results Down 3.6%
- VOW3 GY : German Car Industry to Invest $45 Billion in Electric Vehicles
- VOW3 GY : Volkswagen Brand’s Profitability Falls in 2018: Spiegel

>>> Barrons weekend summary: cautious on food stocks Cover story: For big pharma

Barrons weekend summary: cautious on food stocks

* Cover story: For big pharmaceutical companies struggling to produce drugs that are major breakthroughs in medicine, gene therapy—treatments designed to replace faulty genes with healthy ones—may be the “promised land”; The rich commercial potential of gene therapy has sparked a race among major players including Roche Holding, ONCE, NVS and SRPT; So far the FDA has approved only one gene therapy, but more treatments could pass muster in the coming years as clinical trials demonstrate positive results.

* Features: 1) Cautious on BGS, CPB, CAG, GIS, HSY, HRL, SJM, K, KHC, MKC, MDLZ: Food stocks can no longer be called defensive, as long as wild price swings abound and once-steady growth is disrupted by profound, durable changes in how consumers buy food—and all the major players face challenges on various fronts; 2) The new tax law eliminated personal exemptions for family members, abolished a range of deductions, and curtailed major tax breaks, imposing new caps on home mortgage interest and a $10,000 limit on deductions for state and local taxes—and an estimated 5% of taxpayers will still owe more in tax for 2018; 3) Women have long been at a disadvantage in retirement because they earn less than men, interrupt careers to raise children or care for parents, and live longer—but for single women, the situation is often worse, and their retirement savings tend to be lower than their married—and even widowed—peers.

* Tech Trader: Positive on Samsung, Huawei: Companies view foldable handsets “as the most significant change to the wireless industry since the first-ever smartphones” even as 5G technology is on the horizon; the devices are built on the view that a phone’s physical form is as important as the apps and software running on it.

* Trader: The market isn’t risk-free, says Hugo Rogers of Deltec International Group, who sees continued weakness in economic data from China and Europe, trade hopes baked into stocks, and very little earnings support for the stock market in the U.S.; Cautious on LB: Company may have begun the process of fixing what caused its stock to lose more than half its value in 2018, but investors shouldn’t expect the stock to go up anytime soon; Positive on LITE: Supplier of optical components that counts AAPL as a major customer has a bright future, and shares remain attractive despite weak iPhones sales, which led to a lower forecast in November.

* Interview: Pierre Ferragu of New Street Research Technology joined the firm last year so that he could “make connections and draw insights from disparate industry groups that can sometimes cause turf wars among analysts” (picks: ASML Holding, INTC, TSLA).

* Profile: Ed Perks, lead manager of the Franklin Income fund, a go-anywhere fund that looks across all asset classes to deliver steady income and capital appreciation (top 10 holdings: U.S. Treasuries, CYH, CHK, THC, JPM, WFC, Softbank Group, BAC, WTF, SO).

* Follow-Up: Cautious on GPS: A rally after the company’s announced it would spin off its Old Navy brand provides an opportunity for investors to take some money off the table because share may soon drift lower, but those with patience could see greater rewards.

* European Trader: Positive on RACE: “Recent improvements in the luxury-car maker’s operating performance will probably continue, the stock looks cheap, and the company just gave an optimistic outlook for this year.”

* Emerging Markets: Cautious on MA, AXP: Credit card giants have launched joint ventures in China, a difficult market for them to enter, but investors should “restrain expectations in a market where plastic is locked up by a state monopoly, and rapidly being superseded by mobile payments from online ecosystems” offered by BABA and Tencent.

* Commodities: “Gold prices have pulled back from a 10-month high in recent sessions, leaving investors wondering why the many geopolitical and economic issues plaguing the market haven’t been able to fully support the metal’s haven appeal.”

* Streetwise: WTW continues to try to reinvent itself, but investors should probably hold off buying shares, says columnist Jack Hough, because while some analysts see growth opportunities, others point to enough trouble spots to warrant concern. Related ( AXP CPB GIS CAG SJM MKC GPS K HSY WTW HRL MA BGS MDLZ KHC RACE RACE.IT )

>>> UCB - Presented positive data from the Phase 2b BE ABLE extension study of b

Presented positive data from the Phase 2b BE ABLE extension study of bimekizumab in patients with moderate-to-severe chronic plaque psoriasis

Data showed nearly all BE ABLE 1 responders completing 60 weeks of bimekizumab treatment maintained complete or almost complete skin clearance. The results are the longest-term data so far investigating bimekizumab and further highlight the potential value of the molecule's unique dual mechanism of action, which potently and selectively neutralizes IL-17F in addition to IL-17A, two key cytokines driving inflammatory processes. Findings were presented at a late breaker session at the American Academy of Dermatology Annual Meeting (AAD) in Washington, DC.

"The long-term results observed in the BE ABLE 2 Phase 2b study suggest the meaningful difference that IL-17F inhibition, along with IL-17A inhibition, can make for psoriasis patients who need significant, long-term skin clearance," said Andrew Blauvelt, MD, MBA, an investigator in the trial and President of Oregon Medical Research Center in Portland, Oregon. "The results add to a growing body of evidence supporting the molecule's unique dual neutralization of both IL-17A and IL-17F cytokines across multiple inflammatory diseases, suggesting exciting potential."

"Despite recent advances in therapy, psoriasis patients still have profound unmet needs. Many patients do not experience long-term symptom resolution, and they often have limited confidence in long-term treatments. The positive results and rapid development of bimekizumab in psoriasis reflect UCB's dedication to connecting scientific innovation with greater patient value," said Emmanuel Caeymaex, Head of Immunology and Executive Vice President at UCB.

In the BE ABLE 1 study, up to 79% of patients achieved at least 90% skin clearance (PASI90) as soon as week 12, based on a dose range of 64mg, 160mg, 160mg with a 320mg loading dose, 320mg, or 480mg, administered every four weeks. Among these BE ABLE 1 responders, defined as achievement of PASI90 at week 12, 80-100% maintained the rigorous PASI90 measure for up to an additional 48 weeks based on a dose range of 160mg or 320mg, administered every 4 weeks, in the BE ABLE 2 extension study. Further, 70-83% and 78-100% of BE ABLE 1 responders maintained PASI100 and the Investigator's Global Assessment of response, respectively. The safety profile was consistent with previous studies, with no new safety findings observed. The most frequent treatment-emergent adverse events were oral candidiasis and nasopharyngitis. No cases of suicidal ideation/behavior, major adverse cardiac events, or inflammatory bowel disease were reported.

UCB also presented findings this week from the BE AGILE study of bimekizumab in ankylosing spondylitis and the BE ACTIVE study of bimekizumab in psoriatic arthritis. The safety and efficacy of bimekizumab have not been established, and it is not approved by any regulatory authority worldwide.